Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

le Trottier, BJ, Sachs, Z, DeFor, TE, Shune, L, Dolan, M, Weisdorf, DJ, Ustun, C, Warlick, ED
Foilsithe in Bone Marrow Transplant (2015)

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

le Brunstein, CG, Barker, JN, Weisdorf, DJ, DeFor, TE, McKenna, D, Chong, SY, Miller, JS, McGlave, PB, Wagner, JE
Foilsithe in Bone Marrow Transplant (2009)

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation

le He, F, Verneris, MR, Cooley, S, Blazar, BR, MacMillan, ML, Newell, LF, Panoskaltsis-Mortari, A, DeFor, T, Weisdorf, DJ, Holtan, SG
Foilsithe in Bone Marrow Transplant (2016)

Long-term Outcomes of Adults with Acute Lymphoblastic Leukemia after Autologous or Unrelated Donor Bone Marrow Transplantation: A Comparative Analysis by the National Marrow Donor...

le Bishop, MR, Logan, BR, Gandham, S, Bolwell, BJ, Cahn, J-Y, Lazarus, HH, Litzow, MR, Marks, DI, Wiernik, PH, McCarthy, PL, Russell, JA, Miller, C, Sierra, J, Milone, G, Keating, A, Loberiza, F, Giralt, S, Horowitz, MM, Weisdorf, DJ
Foilsithe 2007